BusinessNetworkNewsWire Announces Publication Discussing the Potential of Cannabinoid-Based Pain TherapiesBy Nasdaq OMXDec 14, 2017, 1:30 PM UTC
BusinessBeyondSpring Meets Primary Objective in Phase 2 Portion of Phase 2/3 Trial (Study 105) with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia (CIN)By Nasdaq OMXDec 14, 2017, 1:01 PM UTC
BusinessKraig Biocraft Laboratories Begins Operations in New LaboratoryBy Nasdaq OMXDec 14, 2017, 11:05 AM UTC
BusinessMyriad’s BRACAnalysis CDx® Test Effectively Identified Metastatic Breast Cancer Patients with Improved Outcomes from Pfizer's PARP Inhibitor, TalazoparibBy Nasdaq OMXDec 12, 2017, 12:05 PM UTC
BusinessFibrocell Announces Closing of $10.5 Million Underwritten Public OfferingBy Nasdaq OMXDec 11, 2017, 9:01 PM UTC
BusinessNew Research Study Demonstrates Applicability of VisionGate’s 3-Dimensional Cell-CT™ Imaging and Analysis PlatformBy Nasdaq OMXDec 11, 2017, 8:27 PM UTC
BusinessPhase 1 Data for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, Presented at 59th Annual ASH MeetingBy Nasdaq OMXDec 11, 2017, 3:45 PM UTC
BusinessAmarantus Subsidiary MANF Therapeutics Receives Notice of Allowance from U.S. Patent & Trademark Office Covering MANF Treatment of DiabetesBy Nasdaq OMXDec 11, 2017, 1:02 PM UTC
